Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thermo Fisher Scientific Inc. has announced a Technology Alliance Agreement with the Chan Zuckerberg Institute for Advanced Biological Imaging (CZ Imaging Institute). This agreement aims to develop new technologies to enable researchers to better ...
read more
Monday, September 18, 2017
Thermo Fisher recently earned the EPA's ENERGY STAR certification for its TSX Series ultra-low temperature freezers, which is designed to reduce energy consumption while ensuring sample protection.
read more
Thermo Fisher Scientific announced Astex Pharmaceuticals selected the Thermo Scientific Glacios Cryo Transmission Electron Microscope to aid in its drug discovery and development program.
read more
Monday, December 09, 2019
Thermo Fisher has expanded its plant in Florida and will open a site in Lexington, Massachusetts as part of plans to invest $125 million in its gene therapy capabilities.
read more
Thermo Fisher Scientific has announced the construction of a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif.
read more
Wednesday, February 07, 2018
Theravance Biopharma has entered into a global co-development and commercialization agreement with Janssen Biotech for TD-1473.
read more
Theravance Biopharma and SciClone Pharmaceuticals have entered into a development and commercialization agreement granting SciClone exclusive development and commercial rights for the antibiotic VIBATIV® (telavancin) in China and certain adjacent ...
read more
BIOTECanada announced earlier today Therapure Biopharma Inc. (Therapure) has been named recipient of a Gold Leaf Award recognizing an outstanding early stage health company. Therapure is being recognized for the potential of their highly innovative ...
read more
Therapure Biopharma has launched its plasma products and technology division as Evolve Biologics, a developer of plasma-derived therapeutics, led by an experienced senior management team.
read more
Friday, September 08, 2017
Therapure Biopharma announced a joint venture between 3SBio and CPE Funds has entered into an agreement to acquire Therapure’s CDMO business and certain rights to plasma products and technology for the Chinese market for US$290 million.
read more
Therapure Biomanufacturing announced approval for the manufacturing of Insmed’s Arikayce at its Mississauga facility by the FDA.
read more
Therapix Biosciences has entered into an exclusive agreement with Catalent Pharma Solutions for the formulation, development and clinical manufacturing of THX-TS01.
read more
Theradex Oncology has announced the release of their proprietary CTMS that provides real-time access to analytics allowing for maximum study visibility for enhanced informed decisions.
read more
Wednesday, September 27, 2023
Theradaptive, a biopharmaceutical company using protein engineering to create targeted therapeutics, has been awarded a U.S. Department of Defense (DOD) Clinical Trial Award of up to $7.4M with options, subject to FDA approval to begin phase I/II ...
read more
Theorem Clinical Research, a leading contract research organization, will demonstrate how its advanced visual analytics tools and techniques provide a faster understanding of complex clinical data during the Drug Information Association’s (DIA) 50th ...
read more